The anastomosis devices market has seen considerable growth due to a variety of factors.
•The market size for anastomosis devices has experienced robust growth of recent years. With a projected growth from $3.66 billion in 2024 to $3.9 billion in 2025, it has a compound annual growth rate (CAGR) of 6.5%.
The growth witnessed in the historic period can be credited to factors such as the surge in surgical procedures, an expanding elderly population, the widespread of chronic diseases, as well as enhancements in healthcare infrastructure, consciousness, and education.
The anastomosis devices market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, a robust expansion is anticipated in the market size of anastomosis devices, predicted to reach $5.21 billion in 2029 with a compound annual growth rate (CAGR) of 7.5%.
The surge during the forecast period can be credited to various factors such as the escalating healthcare expenses worldwide, the widespread application of minimally invasive surgical procedures, the technological progression in the designs of anastomosis devices, the emphasis on patient recovery, and the widespread occurrence of chronic illnesses globally. Leading trends during the projected period will encompass an emphasis on patient recovery and quality of life, the creation of anastomosis sealants, the high prevalence of colorectal illnesses, the increasing aging population worldwide, as well as collaborations and partnerships.
Gain Insights Into The Anastomosis Devices Global Market Report 2025 With A Free Sample Report Here:
The anastomosis device market is poised for growth, driven by the increased demand for surgical procedures. Surgery, wherein an incision is made in a person's body, often requires the use of anastomosis devices. These tools are primarily employed to join two parts of the body, for example, blood vessels or intestines. The rising trend is corroborated by data from The Aesthetic Society, a US organization specializing in plastic surgery and cosmetic medicine. They reported that in August 2023, Americans invested over $11.8 billion in aesthetic operations, marking a 2% rise from the previous year. Thus, as surgical procedures continue to trend upwards, they will fuel the growth of the anastomosis device market.
The anastomosis devices market covered in this report is segmented –
1) By Type: Surgical Staplers, Surgical Sutures, Surgical Sealants and Adhesives, Automated Suturing
2) By Usage: Disposable, Reusable
3) By Application: Cardiovascular And Thoracic Surgery, Gastrointestinal Surgery, Orthopedic Surgery, Gynecological Surgery, Other Applications
4) By End-User: Hospitals, Ambulatory Surgery Centers, Other End-Users
Subsegments:
1) By Surgical Staplers: Manual Surgical Staplers, Automated Surgical Staplers, Endoscopic Staplers
2) By Surgical Sutures: Absorbable Sutures, Non-Absorbable Sutures, Barbed Sutures
3) By Surgical Sealants And Adhesives: Fibrin Sealants, Tissue Adhesives, Cyanoacrylate Adhesives
4) By Automated Suturing: Linear Cutters, Circular Suturing Devices, Robotic Suturing Systems
Advanced tech product introduction is a significant trend shaping the anastomosis device market. To maintain their market share, principal companies are looking to innovate and release state-of-the-art products and technologies. For example, in May 2024, medical device company Ethicon, based in the US, introduced the ECHELON LINEAR Cutter. This revolutionary surgical stapler is engineered to improve surgical results by drastically reducing the possibility of staple line leaks. As per reports, this game-changing device has been shown to produce 47% fewer leaks than conventional staplers, helping decrease potential hazards during and post-surgery. The ECHELON linear cutter's main goal is to reduce leak occurrences at the staple line, vital for preserving tissue closure integrity. Such leaks can result in severe complications like infections and prolonged recovery durations.
Major companies operating in the anastomosis devices market include:
• Medtronic plc
• Synvisc Micro Companies Alliance Inc.
• B. Braun Melsungen AG
• Novare Surgical Systems Inc.
• Dextera Surgical Inc.
• Intuitive Surgical Inc.
• Boston Scientific Corp.
• Artivion Inc.
• Johnson & Johnson Services Inc.
• Röchling Group
• Bluesail Surgical
• Vascular Graft Solutions Ltd.
• Baxter International Inc.
• LivaNova plc
• Getinge AB
• Meril Life Sciences Pvt. Ltd.
• Becton
• Dickinson and Company
• Terumo Corporation
• Teleflex Incorporated
• Scanlan International Inc.
• Microline Surgical Inc.
• Grena Ltd.
• CryoLife Inc.
• Cardica Inc.
• Stryker Corporation
• LifeNet Health Inc.
• Jotec GmbH
• JenaValve Technology Inc.
• Innovia Medical
• Genesee BioMedical Inc.
• EndoEvolution LLC
• Edwards Lifesciences Corporation
• ConMed Corporation
• Cardialen Inc.
North America was the largest region in the anastomosis devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global anastomosis devices market report during the forecast period. The regions covered in the anastomosis devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa